Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes

Abstract

The effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes and the possible mechanisms were investigated in this study. 3T3-L1 preadipocytes were cultured in vitro and treated with different concentrations of ghrelin. Proliferation of 3T3-L1 preadipocytes was evaluated by MTT method and mRNA levels of c-myc and thymidine kinase were detected by RT-PCR. Morphological changes of 3T3-L1 preadipocytes were observed and cell differentiation was measured by oil red O staining. The mRNA levels of peroxisome proliferator-activated receptor γ (PPARγ) and CAAT/enhancer binding protein (C/EBPα) in the cells at different differentiation stages were detected by RT-PCR. The results showed that ghrelin at concentrations of 10⁻⁷ to 10⁻¹⁵ mol/L could significantly promote preadipocyte proliferation (P<0.05), with the most pronounced effect observed at 10⁻¹¹ mol/L (P<0.01). Treatment of 3T3-L1 preadipocytes with ghrelin significantly increased the mRNA levels of c-myc and thymidine kinase (P<0.01). Morphological findings demonstrated that the great amount of lipid droplets appeared in the 3T3-L1 preadipocytes treated with ghrelin. Ghrelin could morphologically induce the differentiation of 3T3-L1 preadipocytes into mature adipocytes. Ghrelin significantly increased the mRNA levels of PPARγ and C/EBPα during the differentiation, when compared with control group (P<0.05). The mRNA levels of PPARγ and C/EBPα were obviously up-regulated with the differentiation of preadipocytes after the treatment of ghrelin. There were significant difference in the mRNA levels of PPARγ and C/EBPα on day 2 and day 8 of the differentiation of 3T3-L1 preadipocytes (P<0.01). In conclusion, ghrelin could promote the proliferation and differentiation of 3T3-L1 preadipocytes by increasing the mRNA levels of PPARγ and C/EBPα and therefore enhance the sensitivity of adipocytes against insulin.

Keywords

ghrelin / preadipocyte / proliferation / differentiation / diabetes

References

[1] KadowakiT., HaraK., YamauchiT., et al. . Molecular mechanism of insulin resistance and obesity. Exp Biol Med, 2003, 228(10): 1111-1117

[2] BoucherJ., QuilliotD., PraderesJ.P., et al. . Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia, 2005, 48(3): 569-577

[3] LacquemantC., VasseurF., LepretreF., et al. . Adipocytokins, obesity and development of type 2 diabetes. Med Sci (Paris), 2005, 21: 10-18

[4] KojimaM., HosodaH., DateY., et al. . Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402(6762): 656-660

[5] TritosN.A., KokkotouE.G.. The physiology and potential clinical applications of ghrelin, a novel peptide hormone. Mayo Clin Proc, 2006, 81(5): 653-660

[6] KershawE.E., FlierJ.S.. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab, 2004, 89(6): 2548-2556

[7] SpiegelmanB.M., FilerJ.S.. Obesity and the regulation of energy balance. Cell, 2001, 104(4): 531-543

[8] TilgH., MoschenA.R.. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol, 2006, 6(10): 772-783

[9] KokkorisP., Pi-SunyerF.X.. Obesity and endocrine disease. Endocrinol Metab Clin North Am, 2003, 32(4): 895-914

[10] PoykkoS.M., KellokoskiE., HorkkoS., et al. . Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 2003, 52(10): 2546-2553

[11] VitaM., HenrikssonM.. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol, 2006, 16(4): 318-330

[12] ZhangX.S., ChenT.Y., WangX.F.. Expression of c-myc, Rb and G1 regulation proteins in breast carcinoma. J Diag Pathol, 2004, 11(3): 159-162

[13] RosenE.D., HusC.H., WangX., et al. . C/EBP alpha induces adipogenesis through PPAR gamma: a unified pathway. Genes Dev, 2002, 16(1): 22-26

[14] LehrkeM., LazarM.A.. The many faces of PPAR gamma. Cell, 2005, 123(6): 993-999

[15] ZuoY., QiangL., FarmerS.R.. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter. J Biol Chem, 2006, 281(12): 7960-7967

[16] RamjiD.P., FokaP.. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J, 2002, 365(3): 561-575